Value through Innovation17 January 2013
Diabetes News and Information
This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Diabetes Press Releases
| 05.06.2012 |
Boehringer Ingelheim and Lilly to feature 30 presentations on type 1 and type 2 diabetes at the 72nd American Diabetes Association Scientific Sessions - EX US & UK. Medical Media Only. |
|---|---|
| 25.05.2012 |
Jentadueto™ (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with Type 2 Diabetes in Europe - For Non-U.S. and Non-UK Media |
| 03.02.2012 |
Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration |
| 31.01.2012 |
FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes - For Non-U.S. and Non-UK Media |
| 08.12.2011 |
Linagliptin demonstrates meaningful improvement in glycaemic control in initial combination therapy with metformin - EX US, UK and UAE Medical Media Only. Under embargo until 08 Dec, 10 am CET |
Diabetes Related News Room
Diabetes Related Documents
Diabetes Video Gallery
-
-
Diabetes Complications Animation
-
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
-
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
-
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)
